1. Home
  2. KLXE vs CELU Comparison

KLXE vs CELU Comparison

Compare KLXE & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KLX Energy Services Holdings Inc.

KLXE

KLX Energy Services Holdings Inc.

HOLD

Current Price

$2.21

Market Cap

39.8M

Sector

Energy

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.28

Market Cap

34.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLXE
CELU
Founded
2018
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.8M
34.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KLXE
CELU
Price
$2.21
$1.28
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
238.3K
64.0K
Earning Date
03-11-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$645,200,000.00
$40,578,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.86
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.46
$1.00
52 Week High
$7.40
$4.35

Technical Indicators

Market Signals
Indicator
KLXE
CELU
Relative Strength Index (RSI) 58.51 44.70
Support Level $2.01 $1.25
Resistance Level $2.25 $1.37
Average True Range (ATR) 0.20 0.09
MACD -0.01 0.02
Stochastic Oscillator 65.44 74.26

Price Performance

Historical Comparison
KLXE
CELU

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: